Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 06-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||
| Net Income | -15,441 | -7,500 | -14,965 |
| Depreciation Amortization | 1,127 | 290 | 531 |
| Other Working Capital | -1,362 | -490 | 2,022 |
| Other Operating Activity | -3,316 | -430 | 3,423 |
| Operating Cash Flow | $-18,992 | $-8,130 | $-8,989 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,410 | -1,120 | -1,697 |
| Net Acquisitions | -1,011 | N/A | 190 |
| Other Investing Activity | 77 | 0 | 13 |
| Investing Cash Flow | $-2,344 | $-1,120 | $-1,495 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -335 | 80 | 56,520 |
| Financing Cash Flow | $-335 | $80 | $56,520 |
| Exchange Rate Effect | 35 | N/A | 0 |
| Beginning Cash Position | 46,367 | 46,470 | 3,933 |
| End Cash Position | 24,732 | 37,310 | 49,970 |
| Net Cash Flow | $-21,635 | $-9,160 | $46,036 |
| Free Cash Flow | |||
| Operating Cash Flow | -18,992 | -8,130 | -8,989 |
| Free Cash Flow | -18,992 | -8,130 | -8,989 |